SLC12A3 and Alzheimer disease: Pal and colleagues [22] found that elevated NCC levels in AD patients are associated with a higher conversion rate from Mild Cognitive Impairment (MCI) to AD, faster disease progression in AD patients, and cognitive decline among both AD and healthy subjects.